Global Asthma Network Symposium 2024

The Global Asthma Network (GAN) is delighted to invite you to attend the

Global Asthma Network Symposium 2024:
Improving access to affordable inhaled medicines for all

On-demand on the SmartLab platform

Register Now

Register Now

This exciting event includes presentations and discussion of GAN Phase I papers and invited perspectives from asthma experts from New Zealand, the Global Initiative for Asthma (GINA), World Health Organization and others

This symposium builds on GAN’s state of the art Global Asthma Report 2022 - www.globalasthmareport.org

The on-demand symposium was launched on the SmartLab platform on 12 February. To access this exciting event, register below for a personalised link and instructions on how to use the SmartLab.

As well as access to the Symposium talks and summaries, you have the opportunity to contribute to discussions about future collaborative work with GAN using a digital online environment called Ludic SmartLab.

We are using the SmartLab to develop ideas for GAN Phase II, the next Global Asthma Report, working with WHO on engaging people with lived experience of asthma, transforming access to affordable inhaled medicines for asthma and several other exciting topics. You can pick and choose what grabs your interest and, as with the Symposium itself, it is completely free to take part in.

This is an important moment in time before the UN High Level Meeting on NCDs in 2025 to make the case for all children, adolescents and adults with asthma to get access to the treatments they need.

View speaker bios

Register Now

Global Asthma Network Symposium 2024

On-demand

Programme:

(click name and title for bio and abstract)
Professor Emeritus Innes Asher, The University of Auckland, NZ Reflections on 30 years of ISAAC and GAN
Dr Sunia Foliaki*, Massey University, Wellington, NZ Spotlight on NZ: Ethnic differences in asthma in New Zealand, GAN Phase I
Dr Sabrina Sapsford, The University of Auckland, NZ Spotlight on NZ: Ethnic differences in eczema in New Zealand (GAN Phase I) - overcoming management obstacles
Professor Cass Byrnes, The University of Auckland, NZ Spotlight on NZ: Outcomes of severe lower respiratory infections in early life
Professor Neil Pearce, London School of Hygiene and Tropical Medicine, UK Childhood asthma time trends
Professor Luis García-Marcos, Universidad de Murcia, Spain The burden of asthma in children and adolescents: GAN Phase I
Professor Chen-Yuan Chiang, The International Union Against Tuberculosis and Lung Disease, Taiwan The burden of asthma in adults: GAN Phase I
Dr Nishtha Singh, Asthma Bhawan, Jaipur, India The burden of asthma in India, the World’s most populous country
Professor Eva Morales, Universidad de Murcia, Spain Asthma management across the life course: GAN Phase I

Improving access to affordable inhaled medicines

Dr Sarah Rylance*, WHO WHO priorities to improve global access to asthma care
Dr Marie Stolbrink, Liverpool School of Tropical Medicine, UK Review of inhaled medicines availability and affordability
Dr Marie Stolbrink, Liverpool School of Tropical Medicine, UK LMIC survey of availability, cost and affordability of inhaled medicines
Dr Marie Stolbrink & Dr Shami Jayasooriya, Liverpool School of Tropical Medicine and University of Sheffield, UK International stakeholder meeting
Professor Asma El Sony*, Epilab, Khartoum, Sudan International collaborations
Dr Karen Bissell, The University of Auckland, NZ Advocacy and the Global Asthma Report
Professor Helen Reddel, GINA, Australia GINA and the case for change
Dr Shami Jayasooriya , University of Sheffield, UK The role of clinical standards
Professor Refiloe Masekela, University of KwaZulu Natal, South Africa Generating the evidence
Dr Sainimere Boladuadua*, University of Auckland, New Zealand Patient Perspectives on Living with Asthma in low- and middle-income countries in the six WHO regions.
Professor Kevin Mortimer, University of Kwazulu-Natal, South Africa The burden of vaccine-preventable diseases in people with asthma and the importance of improving access
Professor Kevin Mortimer, Professor Refiloe Masekela, University of Kwazulu-Natal, South Africa Concluding remarks and continuing our conversation in the SmartLab

Register now

GAN gratefully acknowledges funding from the University of Auckland and Wellcome (Grant number 203919/Z/16/Z) as well as sponsorship from AstraZeneca and GlaxoSmithKline that has helped to make the GAN Symposium 2024 possible. We thank the speakers and the organisations they represent for their contributions including securing their own funding to enable their participation. The Symposium programme was developed independently by the GAN Steering Group.

Attention GAN Collaborators

Our network has been targeted by an email scam. If you receive any unusual requests for assistance from any of the steering group members, please ignore it.

These emails are a common scam that has also targeted many other organisations. Please note we will never make any request for financial assistance from our collaborators. If you have any questions please contact us at info@globalasthmanetwork.org